Risk Factors for Cognitive Impairment in High-Grade Glioma Patients Treated with Postoperative Radiochemotherapy

키워드

참고문헌 (30)

1. Ostrom QT, "CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2008-2012", Neuro Oncol, 17(Suppl 4), pp.iv1~iv62 (2015)
2. Klein M, "Neurobehavioral status and healthrelated quality of life in newly diagnosed high-grade glioma patients", J Clin Oncol, 19, pp.4037~4047 (2001)
3. Tucha O, "Cognitive deficits before treatment among patients with brain tumors", Neurosurgery, 47, pp.324~333 (2000)
4. Sarkissian V, "The sequelae of cranial irradiation on human cognition", Neurosci Lett, 382, pp.118~123 (2005)
5. Armstrong CL, "Late cognitive and radiographic changes related to radiotherapy : initial prospective findings", Neurology, 59, pp.40~48 (2002)
6. Wang M, "Cognition and quality of life after chemotherapy plus radiotherapy (RT) vs. RT for pure and mixed anaplastic oligodendrogliomas: radiation therapy oncology group trial 9402", Int J Radiat Oncol Biol Phys, 77, pp.662~669 (2010)
7. Laack NN, "Cognitive function after radiotherapy for supratentorial low-grade glioma : a North Central Cancer Treatment Group prospective study", Int J Radiat Oncol Biol Phys, 63, pp.1175~1183 (2005)
8. Klein M, "Effect of radiotherapy and other treatmentrelated factors on mid-term to long-term cognitive sequelae in low-grade gliomas : a comparative study", Lancet, 360, pp.1361~1368 (2002)
9. Verger E, "Temozolomide and concomitant whole brain radiotherapy in patients with brain metastases : a phase II randomized trial", Int J Radiat Oncol Biol Phys, 61, pp.185~191 (2005)
10. Antonadou D, "Phase II randomized trial of temozolomide and concurrent radiotherapy in patients with brain metastases", J Clin Oncol, 20, pp.3644~3650 (2002)
11. Saito K, "Toxicity and outcome of radiotherapy with concomitant and adjuvant temozolomide in elderly patients with glioblastoma : a retrospective study", Neurol Med Chir(Tokyo), 54, pp.272~279 (2014)
12. Nasreddine ZS, "The Montreal Cognitive Assessment, MoCA : a brief screening tool for mild cognitive impairment", J Am Geriatr Soc, 53, pp.695~699 (2005)
13. Smith T, "The Montreal Cognitive Assessment : validity and utility in a memory clinic setting", Can J Psychiatry, 52, pp.329~332 (2007)
14. Wang Q, "A prospective longitudinal evaluation of cognition and depression in postoperative patients with high-grade glioma following radiotherapy and chemotherapy", J Cancer Res Ther., 14(Suppl), pp.S1048~S1051 (2018)
15. Durand T, "EpiBrainRad : an epidemiologic study of the neurotoxicity induced by radiotherapy in high grade glioma patients", BMC Neurol, 15, pp.261~ (2015)
16. Dhermain F, "Radiotherapy of high-grade gliomas: current standards and new concepts, innovations in imaging and radiotherapy, and new therapeutic approaches", Chin J Cancer, 33, pp.16~24 (2014)
17. 김병섭, "Concurrent Chemoradiotherapy with Temozolomide Followed by Adjuvant Temozolomide for Newly Diagnosed Glioblastoma Patients: A Retrospective Multicenter Observation Study in Korea", Cancer Research and Treatment, 49(1), pp.193~203 (2017), 대한암학회
18. Kole AJ, "Concurrent chemoradiotherapy versus radiotherapy alone for"biopsy-only"glioblastoma multiforme", Cancer, 122, pp.2364~2370 (2016)
19. Woo PY, "Determining a cut-off residual tumor volume threshold for patients with newly diagnosed glioblastoma treated with temozolomide chemoradiotherapy : a multicenter cohort study", J Clin Neurosci, 63, pp.134~141 (2019)
20. Yang K, "Cancer genetic markers according to radiotherapeutic response in patients with primary glioblastoma : radiogenomic approach for precision medicine", Radiother Oncol, 131, pp.66~74 (2019)
21. Wefel JS, "Neurocognitive function varies by IDH1 genetic mutation status in patients with malignant glioma prior to surgical resection", Neuro Oncol, 18, pp.1656~1663 (2016)
22. Kesler SR, "The effect of IDH1 mutation on the structural connectome in malignant astrocytoma", J Neurooncol, 131, pp.565~574 (2017)
23. Jiang X, "O6-methylguanine-DNA methyltransferase(MGMT)immunohistochemistry as a predictor of resistance to temozolomide in primary CNS lymphoma", J Neurooncol, 114, pp.135~140 (2013)
24. Binabaj MM, "The prognostic value of MGMT promoter methylation in glioblastoma : a meta-analysis of clinical trials", J Cell Physiol, 233, pp.378~386 (2018)
25. Smrdel U, "Long-term survival in glioblastoma : methyl guanine methyl transferase(MGMT)promoter methylation as independent favourable prognostic factor", Radiol Oncol, 50, pp.394~401 (2016)
26. Liu Y, "Genetic modulation of neurocognitive function in glioma patients", Clin Cancer Res, 21, pp.3340~3346 (2015)
27. Miotto EC, "Cognitive impairments in patients with low grade gliomas and high grade gliomas", Arq Neuropsiquiatr, 69, pp.596~601 (2011)
28. Noll KR, "Relationships between tumor grade and neurocognitive functioning in patients with glioma of the left temporal lobe prior to surgical resection", Neuro Oncol, 17, pp.580~587 (2015)
29. Surma-aho O, "Adverse long-term effects of brain radiotherapy in adult low-grade glioma patients", Neurology, 56, pp.1285~1290 (2001)
30. Talacchi A, "Cognitive effects of tumour and surgical treatment in glioma patients", J Neurooncol, 103, pp.541~549 (2011)

관련 논문AI추천